These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6778533)

  • 1. Attempt at enzyme replacement in Gaucher disease by renal transplantation.
    Groth CG; Collste H; Dreborg S; Håkansson G; Lundgren G; Svennerholm L
    Birth Defects Orig Artic Ser; 1980; 16(1):475-90. PubMed ID: 6778533
    [No Abstract]   [Full Text] [Related]  

  • 2. Attempt at enzyme replacement in Gaucher disease by renal transplantation.
    Groth CG; Collste H; Dreborg S; Håkansson G; Lundgren G; Svennerholm L
    Acta Paediatr Scand; 1979 Jul; 68(4):475-9. PubMed ID: 380259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attempt at enzyme replacement by organ transplantation: renal transplantation in Gaucher disease.
    Groth CG; Collste H; Dreborg S; Håkansson G; Lundgren G; Svennerholm L
    Transplant Proc; 1979 Jun; 11(2):1218-9. PubMed ID: 382486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher's disease, a review.
    Peters SP; Lee RE; Glew RH
    Medicine (Baltimore); 1977 Sep; 56(5):425-42. PubMed ID: 329054
    [No Abstract]   [Full Text] [Related]  

  • 5. Infantile Gaucher's disease: glucocerebrosidase deficiency in peripheral blood leukocytes and cultured fibroblasts.
    Sengers RC; Lamers KJ; Bakkeren JA; Schretlen ED; Trijbels JM
    Neuropadiatrie; 1975 Nov; 6(4):377-82. PubMed ID: 241947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal transplantation in Type II Gaucher disease.
    Desnick SJ; Desnick RJ; Brady RO; Pentchev PG; Simmons RL; Najarian JS; Swaiman K; Sharp HL; Krivit W
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):109-19. PubMed ID: 4611522
    [No Abstract]   [Full Text] [Related]  

  • 7. Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations.
    Svennerholm L; Dreborg S; Erikson A; Groth CG; Hillborg PO; Håkansson G; Nilsson O; Tibblin E
    Prog Clin Biol Res; 1982; 95():67-94. PubMed ID: 6812091
    [No Abstract]   [Full Text] [Related]  

  • 8. beta-Glucosidase isoenzymes in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with type 1 Gaucher disease.
    Maret A; Salvayre R; Samadi M; Douste-Blazy L
    Enzyme; 1987; 37(4):208-17. PubMed ID: 3038513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors and stimulators of glucocerebroside metabolism.
    Radin NS
    Prog Clin Biol Res; 1982; 95():357-83. PubMed ID: 6214799
    [No Abstract]   [Full Text] [Related]  

  • 10. Mammalian glucocerebrosidase: implications for Gaucher's disease.
    Glew RH; Basu A; LaMarco KL; Prence EM
    Lab Invest; 1988 Jan; 58(1):5-25. PubMed ID: 3275832
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation in Gaucher's disease: effect of mixed chimeric state.
    Chan KW; Wong LT; Applegarth D; Davidson AG
    Bone Marrow Transplant; 1994 Aug; 14(2):327-30. PubMed ID: 7994251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebroside-beta-glucosidase activity in Gaucher brain.
    Svennerholm L; Månsson JE; Rosengren B
    Clin Genet; 1986 Aug; 30(2):131-5. PubMed ID: 3757304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gaucher Disease].
    Okuyama T
    Brain Nerve; 2015 Sep; 67(9):1109-13. PubMed ID: 26329151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple glycosidase deficiencies in a case of juvenile (type 3) Gaucher disease.
    Chiao YB; Hoyson GM; Peters SP; Lee RE; Diven W; Murphy JV; Glew RH
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2448-52. PubMed ID: 27787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients.
    Choy FY; Davidson RG
    Am J Hum Genet; 1980 Sep; 32(5):670-80. PubMed ID: 6775530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current therapeutic focus in type I Gaucher's disease].
    Pérez Calvo JI; Pastores GM; Isola L; Giraldo P; Bueno Gómez J
    Sangre (Barc); 1994 Feb; 39(1):39-44. PubMed ID: 8197518
    [No Abstract]   [Full Text] [Related]  

  • 17. [Principles of diagnosis and the clinical course of 8 cases of Gaucher's disease (beta-glucocerebrosidase deficiency)].
    Tylki-Szymańska A; Maciejko D; Rujner J; Goryluk B; Pronicka E
    Pediatr Pol; 1987 Jan; 62(1):9-18. PubMed ID: 3615053
    [No Abstract]   [Full Text] [Related]  

  • 18. Qualitative characteristics of the beta-glucosidase isozymes.
    Choy FY; Davidson RG
    Prog Clin Biol Res; 1982; 95():415-41. PubMed ID: 6812079
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucocerebroside-beta-glucosidase isozymes.
    Ginns EI; Brady RO; Stowens DW; Furbish FS; Barranger JA
    Prog Clin Biol Res; 1982; 95():405-14. PubMed ID: 7122639
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple forms of beta-glucosidase in Gaucher disease.
    Yaqoob M; Carroll M
    Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.